PARVOVIRUS B19 INFECTION REACTIVATION

This adverse event was reported 32 times

These drugs are most commonly taken by patients reporting PARVOVIRUS B19 INFECTION REACTIVATION:

# Drug Count
0 TACROLIMUS 19
1 TACROLIMUS EXTENDED-RELEASE CAPSULES 18
2 TACROLIMUS OINTMENT 0.1% 18
3 MYCOPHENILIC ACID 11
4 MYCOPHENOLIC ACID 11
5 RITUXIMAB 10
6 CYCLOSPORINE 8
7 MYCOPHENOLATE MOFETIL 7
8 PREDNISONE 7
9 SIROLIMUS 7
See all common drugs associated with PARVOVIRUS B19 INFECTION REACTIVATION

PARVOVIRUS B19 INFECTION REACTIVATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MYCOPHENILIC ACID 11 0.0005
1 SIROLIMUS 7 0.0005
2 CEFOTAXIME INJECTION 2 0.0005
3 TECLISTAMAB-CQYV 1 0.0004
4 (DAUNORUBICIN AND CYTARABINE) LIPOSOME 1 0.0004
5 MYCOPHENOLIC ACID 11 0.0003
6 HUMAN IMMUNOGLOBULIN G 4 0.0002
7 GANCICLOVIR SODIUM 2 0.0002
8 EVEROLIMUS TABLETS 3 0.0002
9 TACROLIMUS OINTMENT 0.1% 18 0.0001
See all drugs enriched for association with PARVOVIRUS B19 INFECTION REACTIVATION